Arkolith/Insider Trading/VYNE/Form 4

Lepore Patrick G

DirectorVYNE Therapeutics Inc. (VYNE) · full profile →Form 4 · filed Nov 17, 2023
Net Buying
Open-Market Buys
$51K
Open-Market Sells
$0
Net Open-Market Flow
$51K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2023Buy(P)13K$3.91$51K36K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-055787) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML